BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 38632185)

  • 21. Metabolic Inflammation and Insulin Resistance in Obesity.
    Wu H; Ballantyne CM
    Circ Res; 2020 May; 126(11):1549-1564. PubMed ID: 32437299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lisofylline mitigates cardiac inflammation in a mouse model of obesity through improving insulin secretion and activating cardiac AMPK signaling pathway.
    Ali M; Bakr MH; Abdelzaher LA; Sayed SA; Mali V; Desai AA; Radwan E
    Cytokine; 2021 Feb; 138():155398. PubMed ID: 33341003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endothelial and Perivascular Adipose Tissue Abnormalities in Obesity-Related Vascular Dysfunction: Novel Targets for Treatment.
    Schinzari F; Tesauro M; Cardillo C
    J Cardiovasc Pharmacol; 2017 Jun; 69(6):360-368. PubMed ID: 28141700
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Role of the Nrf2 Signaling in Obesity and Insulin Resistance.
    Li S; Eguchi N; Lau H; Ichii H
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32971975
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Obesity-induced type 2 diabetes impairs neurological recovery after stroke in correlation with decreased neurogenesis and persistent atrophy of parvalbumin-positive interneurons.
    Pintana H; Lietzau G; Augestad IL; Chiazza F; Nyström T; Patrone C; Darsalia V
    Clin Sci (Lond); 2019 Jul; 133(13):1367-1386. PubMed ID: 31235555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Obesity, inflammation, and insulin resistance--a mini-review.
    Zeyda M; Stulnig TM
    Gerontology; 2009; 55(4):379-86. PubMed ID: 19365105
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanisms linking obesity and cancer.
    Louie SM; Roberts LS; Nomura DK
    Biochim Biophys Acta; 2013 Oct; 1831(10):1499-508. PubMed ID: 23470257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Leptin and insulin pathways in POMC and AgRP neurons that modulate energy balance and glucose homeostasis.
    Varela L; Horvath TL
    EMBO Rep; 2012 Dec; 13(12):1079-86. PubMed ID: 23146889
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adipokines: molecular links between obesity and atheroslcerosis.
    Lau DC; Dhillon B; Yan H; Szmitko PE; Verma S
    Am J Physiol Heart Circ Physiol; 2005 May; 288(5):H2031-41. PubMed ID: 15653761
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inflammation-mediated metabolic regulation in adipose tissue.
    Xu S; Lu F; Gao J; Yuan Y
    Obes Rev; 2024 Jun; 25(6):e13724. PubMed ID: 38408757
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
    Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
    Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An Interplay between Obesity and Inflammation in Gestational Diabetes Mellitus.
    Skórzyńska-Dziduszko KE; Kimber-Trojnar Ż; Patro-Małysza J; Olszewska A; Zaborowski T; Małecka-Massalska T
    Curr Pharm Biotechnol; 2016; 17(7):603-13. PubMed ID: 26813307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of mineralocorticoid receptor signaling in the cross-talk between adipose tissue and the vascular wall.
    Jia G; Aroor AR; Sowers JR
    Cardiovasc Res; 2017 Jul; 113(9):1055-1063. PubMed ID: 28838041
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanistic Links Between Obesity, Diabetes, and Blood Pressure: Role of Perivascular Adipose Tissue.
    Saxton SN; Clark BJ; Withers SB; Eringa EC; Heagerty AM
    Physiol Rev; 2019 Oct; 99(4):1701-1763. PubMed ID: 31339053
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adipose Tissue Dysfunction as Determinant of Obesity-Associated Metabolic Complications.
    Longo M; Zatterale F; Naderi J; Parrillo L; Formisano P; Raciti GA; Beguinot F; Miele C
    Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31085992
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasminogen activator inhibitor links obesity and thrombotic cerebrovascular diseases: The roles of PAI-1 and obesity on stroke.
    Chen R; Yan J; Liu P; Wang Z; Wang C
    Metab Brain Dis; 2017 Jun; 32(3):667-673. PubMed ID: 28378106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biological Mechanisms for the Effect of Obesity on Cancer Risk: Experimental Evidence.
    Berriel Diaz M; Herzig S; Schafmeier T
    Recent Results Cancer Res; 2016; 208():219-242. PubMed ID: 27909910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential effects of leptin on adiponectin expression with weight gain versus obesity.
    Singh P; Sharma P; Sahakyan KR; Davison DE; Sert-Kuniyoshi FH; Romero-Corral A; Swain JM; Jensen MD; Lopez-Jimenez F; Kara T; Somers VK
    Int J Obes (Lond); 2016 Feb; 40(2):266-74. PubMed ID: 26374448
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Link Between Adipose Tissue Renin-Angiotensin-Aldosterone System Signaling and Obesity-Associated Hypertension.
    Schütten MT; Houben AJ; de Leeuw PW; Stehouwer CD
    Physiology (Bethesda); 2017 May; 32(3):197-209. PubMed ID: 28404736
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Body composition, inflammation and thermogenesis in pathways to obesity and the metabolic syndrome: an overview.
    Dulloo AG; Montani JP
    Obes Rev; 2012 Dec; 13 Suppl 2():1-5. PubMed ID: 23107254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.